British pharmaceutical giant AstraZeneca Plc got the green signal from the U.S. Food and Drug Administration (FDA) Wednesday, for its new drug vandetanib for the treatment of a rare form of thyroid cancer.
The Food and Drug Administration (FDA) has cleared Benlysta, the first new drug to treat lupus in 56 years, designed to relieve flare-ups and pain in certain patients who are receiving standard therapy for the deadly autoimmune disease.
Ever imagined losing weight through chocolates and cakes? Well, mouth-watering desserts to help people shed flab is soon going to become a reality.
Genentech, a Roche subsidiary, has been informed through a letter by the Food and Drug Administration (FDA) that the federal agency is ready to give another chance to the company to argue in favour of of ‘Avastin’ a drug for breast cancer.
On Friday, the Food and Drug Administration (FDA) granted approval to Selenia Dimensions digital breast tomosynthesis system marketed by Hologic Inc. of Bedford, Mass., the first such device to be sold in the nation that will produce three-dimensional images of the breast for cancer screening and diagnosis.
Finally a drug option to prevent preterm births. Researchers claim that it can help at-risk pregnant women reach full term.
Anyone who's kept an eye on the drugmakers this year won't be surprised by this statistic: The Food and Drug Administration approved fewer drugs this year than it has since 2007. According to the Wall Street Journal, which took the time to add them all up, the FDA only approved 21 drugs this year, compared with 25 in 2009 and 24 in 2008.
In what can be termed as significant step in the prevention of anal cancer, the U.S. Food and Drug Administration (FDA) has given regulatory approval to Gardasil, a human papillomavirus vaccine.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.